The Biden administration announced on Tuesday the first 10 drugs it plans to target to reduce the federal government's costs and out-of-pocket expenses for Medicare recipients. The negotiations are a part of the Inflation Reduction Act, but there are at least eight lawsuits from pharmaceutical companies trying to block the move. CBS News' Weijia Jiang reports.
